4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0000899243-22-006427
Chief Development Officer acquired 28,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Michaelson Jennifer · Chief Development Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-02-11 | Grant or award : show line 1 in the form | +28,500 | 51,411 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-02-11 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +57,000 | 57,000 | D |
Loading xslF345X03/doc4.xml…